Cellyrix Therapeutics Israeli Company

Cellyrix leverages an advanced computational pipeline integrated with high-throughput experimental screening to discover and develop therapeutics that facilitate transitions from aggressive cell states to less malignant ones. The company is pioneering targeted therapies tailored to combat resistant cell states, guided by biomarkers derived from the cell state composition of tumors.